Brief: PYC Therapeutics Ltd Seeks Trading Halt
07/06/2021 02:35
June 7 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* TRADING HALT-PYC.AX
* REQUESTS TRADING HALT REGARDING RESULTS FROM ASSESSMENT OF
EFFECTIVENESS OF SECOND INVESTIGATIONAL DRUG CANDIDATE
Source text for Eikon: urn:newsml:reuters.com:*:nASX8jNwr3
Further company coverage: PYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director